Uniform-sized PLA nanoparticles: Preparation by premix membrane emulsification

Qiang Wei, Bo Lai, Lian-Yan Wang, Yu‐Xia Wang, Zhiguo Su, Guanghui MaInternational Journal of Pharmaceutics 2008 · DOI

TL;DR

This paper introduces a novel, facile method for preparing uniform-sized polylactide (PLA) nanoparticles using a combination of emulsion-solvent removal and premix membrane emulsification. This technique addresses the critical challenge of achieving narrow size distribution in biodegradable nanoparticles, which is essential for predictable drug delivery and biodistribution.

What Problem Does This Paper Address?

Biodegradable nanoparticles are a promising platform for drug delivery, offering advantages like controlled release and targeted delivery. However, a major hurdle in their development is achieving consistent and narrow particle size distribution. Traditional methods like high-speed homogenization or ultrasonication often result in broad size ranges, leading to unpredictable drug release, variable biodistribution, and difficulties in reproducibility. Furthermore, the high energy input in some methods can compromise the stability of encapsulated drugs. Existing methods for achieving uniform sizes, such as selective centrifugation, are often tedious and inefficient, making industrial-scale production a significant challenge. This paper aims to bridge this gap by developing a simple, scalable, and reproducible method for producing uniform-sized biodegradable nanoparticles.

Methods

The authors propose a two-step approach:

  1. Coarse Emulsion Preparation: A standard low-speed stator homogenization is used to create an initial coarse emulsion.
  2. Premix Membrane Emulsification: This coarse emulsion is then subjected to high-pressure extrusion through a Shirasu porous glass (SPG) membrane. This process breaks down the larger droplets into uniform nanodroplets. The organic solvent (ethyl acetate in this case) then evaporates overnight, and the resulting nanoparticles are washed and collected.

The novelty lies in the combination of these steps and the application of high pressure during membrane emulsification to achieve precise droplet size control. Factors investigated for their influence on nanoparticle size and distribution include the type of organic solvent, the volume ratio of oil to external water phase, the pore size of the SPG membrane, and the transmembrane pressure.

Datasets

Not discussed in the paper. The study uses polylactide (PLA) as a model polymer and Bovine Serum Albumin (BSA) as a model drug for encapsulation studies.

Key Insights and Ideas

  • High Pressure is Key: The study highlights that high transmembrane pressure during membrane emulsification is crucial for breaking down coarse emulsion droplets into uniform nanodroplets. This high pressure accelerates the process and improves droplet disruption.
  • Solvent Choice Matters: Methylene chloride, a common organic solvent, was found to be unsuitable because its volatility led to rapid solidification and pore jamming. Ethyl acetate was chosen due to its lower volatility, relatively high boiling point, and ease of extraction, which is beneficial for drug encapsulation efficiency.
  • Optimizing Parameters for Uniformity: The research systematically investigated how various parameters influence nanoparticle size and distribution, providing a roadmap for achieving desired outcomes.
  • Scalability and Simplicity: The method is presented as being simple, with potential for easy scale-up by increasing membrane surface area or using parallel membrane configurations, making it attractive for industrial applications.

Key Results

  • Uniformity Achieved: Under optimized conditions, the coefficient of variation (CV) value for PLA nanoparticles could be controlled below 16.9%, indicating a narrow size distribution.
  • Parameter Effects:
    • Volume Ratio: Increasing the volume ratio of the external water phase led to larger particle sizes and broader distributions, likely due to increased viscosity of the oil droplet as ethyl acetate diffused into the water.
  • Pore Size: Smaller pore sizes of the SPG membrane were required to achieve uniform-sized nanoparticles. Larger pores allowed bigger droplets to pass through, resulting in broader distributions.
  • Transmembrane Pressure: Increasing transmembrane pressure resulted in smaller particle sizes and narrower size distributions. A good linear relationship was observed between mean size and transmembrane pressure, allowing for size control.
  • Drug Encapsulation: When BSA was used as a model drug, the nanoparticles achieved a loading of 8.09 µg BSA/mg particle and an encapsulation efficiency of 32.3%, with no apparent negative impact on the uniformity or sphericity of the drug-loaded nanoparticles.

Limitations and Future Work

  • Limitations: The paper acknowledges that while uniform-sized nanoparticles were prepared, the specific applications of these nanoparticles are still under investigation. The study focused on PLA as a model polymer.
  • Future Work: The authors plan to further investigate the application of these novel nanoparticles in drug delivery. They also intend to explore the preparation of uniform-sized nanoparticles using other materials, such as chitosan.

Summary updated

BibTeX
@article{wei2008uniform,
  author = {Qiang Wei and Wei Wei and Bo Lai and Lian-Yan Wang and Yu‐Xia Wang and Zhiguo Su and Guanghui Ma},
  title = {{Uniform-sized PLA nanoparticles: Preparation by premix membrane emulsification}},
  journal = {International Journal of Pharmaceutics},
  year = {2008},
  doi = {10.1016/j.ijpharm.2008.03.027},
}
Figure